FDA Device Intelligence
Home › US Endoscopy › Traxtion

Traxtion

US Endoscopy · Model 00711113 · UDI-DI 00816765010990

FDI Prescription
10
510(k) clearances
4,640
Adverse events (10 deaths)
18
Recalls
60
Facilities

Description

The Traxtion hexagonal snare is an electrosurgical device used to grasp, dissect and transect tissue during gastrointestinal endoscopic procedures, and used with diathermic energy.

Recalls

DateFirmReason
2025-10-06Olympus Corporation of the AmericasSterility compromised from small holes that may occur during packaging of the device pouches into the shelf carton and/or during transportation of the shelf carton.
2025-10-06Olympus Corporation of the AmericasSterility compromised from small holes that may occur during packaging of the device pouches into the shelf carton and/or during transportation of the shelf carton.
2021-01-19Boston Scientific CorporationPackaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient.
2021-01-19Boston Scientific CorporationPackaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient.
2021-01-19Boston Scientific CorporationPackaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient.
2020-07-06Boston Scientific CorporationBSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr
2020-07-06Boston Scientific CorporationBSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr
2020-07-06Boston Scientific CorporationBSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr
2020-07-06Boston Scientific CorporationBSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr
2020-07-06Boston Scientific CorporationBSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.